-
-
-
-
-
-
-
H.C. Wainwright Reinstates First Wave BioPharma (FWBI) at Neutral following ImmunogenX deal and capital raise
-
-
-
-
-
-
-
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
-
-
-
-
-
-
-
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
-
-
-
-
-
-
-
First Wave BioPharma To Present at the BIO Investor Forum
-
-
-
-
-
-
-
First Wave BioPharma (FWBI) Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation
-
-
-
-
-
-
-
First Wave BioPharma to Attend the 36th National Cystic Fibrosis Education Conference (July 28-30)
-
-
-
-
-
-
-
First Wave BioPharma to Participate in EF Hutton Inaugural Global Conference
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

